Practice Support Update Blog

Levemir® to be permanently discontinued

Nov 29, 2023 2:00:00 PM / by Practice Support Team

Diagnosis - Diabetes. Medical Concept with Red Pills, Injections and Syringe. Selective Focus. 3D Render.

Novo Nordisk has announced the permanent discontinuation of all formulations of Levemir.  Supply disruptions of Levemir FlexPen are expected to begin in mid-January 2024, followed by the complete discontinuation of the FlexPen on April 1, 2024. The Levemir vial will be discontinued on December 31, 2024.

See the announcement from the manufacturer here.

Novo Nordisk will continue to provide Levemir to pharmacies and wholesalers while supplies last.  In order to maintain continuity of care, patients using Levemir are encouraged to discuss alternative treatment options with their healthcare provider before products are no longer available.

For patients on Medicaid, Levemir will remain preferred on the Preferred Drug List (PDL) so that claims will continue to pay until any remaining stock is depleted.




Tags: Primary Care, family medicine, diabetes, Adult health

  • There are no suggestions because the search field is empty.

Practice Support Services

Health care practices in North Carolina face many challenges. Our team of quality improvement coaches (QICs) have skills and expertise to support you in your transformation efforts.

To learn more about Practice Support Click Here

Apply for practice support services - fill out an application here

Subscribe to Blog Updates

Additional Resources:
Tip Sheets
Lib Guides
Interactive Resource Guides
Digital Library
New call-to-action
Join email list

Connect With Us:

Posts by Topic

See all

In Case You Missed It... Check Out These Recent Posts